In value terms, immuno-oncology-related deal activity increased by 244% in Q4 2023 compared with the previous quarter’s total of $552.8m and fell by 94% as compared to Q4 2022. Related deal volume increased by 56% in Q4 2023 versus the previous quarter.
The top-ranked financial advisors supporting these M&A deals in Q4 2023 were Centerview Partners; SVB Financial Group; Toronto-Dominion Bank with 4, 4, 3 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Q4 2023 were Cooley; Gibson, Dunn & Crutcher; Goodwin Procter with 6, 6, 5 deals respectively.
For further understanding of GlobalData’s Pharmaceuticals Industry M&A Deals by Top Themes in 2023 – Thematic Intelligence, buy the report here.
Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Company Profile – free
sample
Your download email will arrive shortly
We are confident about the
unique
quality of our Company Profiles. However, we want you to make the most
beneficial
decision for your business, so we offer a free sample that you can download by
submitting the below form
By GlobalData
Source link
#immunooncology #related #activity #pharmaceutical #industry
